WO2018203879A1

WO2018203879A1 - Anti-viral compositions and method

Info

Publication number: WO2018203879A1
Application number: PCT/US2017/030472
Authority: WO
Inventors: Iraj E. Kiani
Original assignee: Individual
Current assignee: Individual
Priority date: 2017-05-01
Filing date: 2017-05-01
Publication date: 2018-11-08
Anticipated expiration: 2019-11-01
Also published as: EP3600555A4; CN110740785A; EP3600555A1; JP2019515870A

Abstract

An antiviral composition and a method of treating viral conditions comprising a silver-containing substance, such as colloidal silver, silver nitrate, or a combination thereof, an antiviral natural herb or a natural herb from the Rutaceae family, such as Ruta graveolens, Myrtaceae family, such as Melaleuca alternifoiia, Cupressaceae family, such as Thuja occidentalis, and the Moraceae family, such as fig, or any combination thereof, and vinegar, such as red vinegar.

Description

ANTI-VIRAL COMPOSITIONS AND METHOD

TECHNICAL FIELD

[0001] This invention relates to compositions and methods for treating viral conditions.

BACKGROUND

[0002] Viruses have long plagued the earth resulting in conditions ranging from simple to severe discomfort (e.g., warts, HPV, herpes, and shingles) to death (e.g., HIV and cancer). Unlike bacterial and fungal infections, viral infections have proven difficult to treat, partly due to the fact that viral infections involve injection of the virus's genetic material into the host cell and partly because of the virus's ability to mutate.

[0003] Despite advances in technology and scientific research, pathogens, such as viruses, bacteria, fungus, and other microorganisms, continue to cause disease, disorders, and dysfunctions. Current treatments suffer from inefficacy and/or undesirable side effects. Oftentimes treatments that are effective for one patient are not effective for another. Thus, scientists and physicians are in continual pursuit of new treatments and drugs that are more effective, less toxic, and easily produced.

DISCLOSURE OF INVENTION

[0004] The present invention is directed to an antiviral composition and a method for the treating viral infections comprising, among other things, a silver-containing substance, such as colloidal silver, silver nitrate, other silver derivative, or some combination thereof, red vinegar, and one or more antiviral natural herbs, such as fig, unripe fig or fig latex.

MODES OF CARRYING OUT INVENTION

[0005] The detailed description set forth below in connection with the appended drawings is intended as a description of presently-preferred embodiments of the invention and is not intended to represent the only forms in which the present invention may be constructed or utilized. It is to be understood that the same or equivalent functions and compositions may be accomplished by different embodiments that are also intended to be encompassed within the spirit and scope of the invention. [0006] The present invention is directed towards a method and composition for the prevention and/or treatment of a viral condition or disorder caused by a pathogen using a transition metal, such as a silver-containing substance, and one or more natural herbs. In some embodiments, the composition may further comprise vinegar. Diseases, disorders, or conditions caused by such pathogens include, without limitation, cancer, warts, genital warts, herpes, shingles, genital herpes, and infections caused by the human papilloma virus.

[0007] One embodiment is an antiviral composition for treating a viral condition, comprising a therapeutically effective amount of a silver-containing substance and a therapeutically effective amount of a natural herb. In some embodiments, the antiviral composition may further comprise a therapeutically effective amount of vinegar.

[0008] The silver-containing substance may be colloidal silver, silver nitrate, other silver-bearing materials or by-products, or any combination thereof. The silver-containing substance may be present in an amount from approximately 1 % to approximately 75 % by weight of the total composition. In another embodiment, the amount of such silver- containing substances may be approximately 1 % to approximately 50% of the composition by weight. In more typical embodiments, the amount of the silver-containing substance may be approximately 1 % to approximately 25 % of the composition by weight.

[0009] A natural herb as used in this application includes, among other tilings, fig, unripe fig, and fig latex. The natural herb may be from, for example, without limitation, any and all portions of the evergreen shrubs of the Rutaceae family, for example the Ruta genus; the Myrtaceae family, and more specifically, the Melaleuca genus for example, including any fruits, seeds, flowers, leaves, stems, bark, oils, and the like. Alternatively, or in combination with the forgoing, the natural herb could also be derived from any and all portions of the woody trees, shrubs, and vines of the Moraceae family, for example the Ficus genus; the evergreen coniferous tree in the cypress family Cupressaceae, for example the Thuja genus; or any combination thereof, including any fruits, seeds, flowers, leaves, stems, bark, oils, and the like. Other examples of herbs that may be used in the present composition include, any and all portions of the herb, including any fruits, seeds, flowers, leaves, stems, bark, oils, and the like, of Ruta Graveolens of the Rutaceae family, Melaleuca Alternifolia, also known as Narrow-leaved Paperbark, Narrow-leaved Tea-tree, Narrow-leaved Ti-tree, or Snow-in-summer from the Myrtaceae family; Thuja Occidentalis from the Cupressaceae family; or figs, unripe figs, or fig latex from the Moraceae family, or any combination thereof.

[0010] Natural herbs may also include, antiviral natural herbs (also referred to as antiviral herbs) defined herein to include without limitation, any and all portions (including any fruits, seeds, flowers, leaves, stems, bark, oils, and the like) of Echinacea, Allium sativum (garlic), Glycyrrhiza glabra (licorice root), Astragalus, Scutellaria baicalensis, Cinchona bark, Zingiber officinale (ginger), grapefruit seed extract, Lonicera japonica (honeysuckle), Olea europea (olive leaf), Sambucus nigra (black elderberry), Rudbeckia (black-eyed Susan root), Forsythia suspensa (forsythia), Isatis tinctora (isatidis), Lomatium dissecutim (leptotaenia), and Schizandra chinensis (schizandra), Croton lechleri (dragon's blood), Hydrastis Canadensis (goldenseal), Juniperus (juniper), Melissa officinalis (lemon balm), Lentinus edodes (shiitake), and Eucalyptus globules (eucalyptus). These antiviral natural herbs produce their antiviral effects by reducing further spread of the infection and/or by boosting the immune system's response to the infection.

[0011] The Applicant believes that such natural herbs and antiviral natural herbs themselves have very limited efficacy, if any, as an antiviral agent on their own. The administration of silver-containing or silver-bearing substances, such as colloidal silver, silver nitrate, silver derivative materials, or a combination thereof, in combination with natural herbs, including antiviral natural herbs, however, appears to have greatly superior effects that improve the efficacy of the antiviral properties of the composition far beyond the effectiveness of any of these components alone.

[0012] The antiviral herb or the natural herb may be present in amounts between approximately 25% to approximately 99% by weight of the total composition. Preferably, the anti-viral natural herb or the natural herb is present in amounts between approximately 50% to approximately 99% by weight of total composition. More preferably, the antiviral natural herb or the natural herb is present in amounts between approximately 75% to approximately 99% by weight of total composition.

[0013] In some embodiments, the efficacy of the antiviral composition of the present invention may be further improved with the addition of vinegar. Vinegar is created by the fermentation of ethanol into acetic acid by certain bacteria. Many different types of vinegar may be used, such as apple cider, balsamic, cane, coconut, date, distilled, East Asian black, fruit, honey, Job's tears, kiwifruit, kombucha, malt, palm, pomegranate, raisin, rice, sherry, spirit, white, and wine vinegar. In the preferred embodiment, the vinegar is red vinegar.

[0014] Vinegar may be present in an amount from approximately 5 % to approximately 90% of the total weight of the composition. Preferably, vinegar is present in an amount from approximately 25% to approximately 75% by weight of the composition. More preferably, vinegar may be present in an amount from approximately 30% to approximately 40% by weight of the composition.

[0015] In embodiments containing vinegar, the amount of the natural herb (including the antiviral natural herb) may be adjusted. For example, when vinegar is present in the composition, the natural herb may be present in an amount from approximately 9% to approximately 94% by weight of the composition. Preferably, the herb may be present in an amount from 24% to approximately 74% by weight of the composition. More preferably, the herb may be present in an amount from 35% to approximately 69% by weight of the composition.

[0016] The invention of the present application may also be directed towards a method of treating a viral condition, comprising administering a therapeutically effective amount of the antiviral composition comprising the silver-containing substance and the natural herb, whereby the viral condition is ameliorated. In some embodiments, the method of treating a viral condition may comprise administering a therapeutically effective amount of the antiviral composition comprising the silver-containing substance, the natural herb, and vinegar, whereby the viral condition is ameliorated.

[0017] The administration step may be any method of drug delivery, for example, topical application, oral administration, patch application, rinse solution, subcutaneous injection, or the like. Most typically, the composition is administered by topical application. Topical application includes any application resulting in administration of the composition to the surface of the skin. Generally, one or few drops (depends on the size of lesions) of the composition are sufficient for small treatment areas of 1 millimeter diameter or less. Preferably, a sufficient amount of the composition should be applied such that any sores, lesions, neoplasm, or tumors are sufficiently covered.

[0018] In embodiments administered topically, the composition may further comprise a cream, gel, ointment, tablet, capsule, patch and the like to prolong the contact between the active ingredients and the point of treatment on the skin. [0019] In many embodiments, the composition of the present invention may be administered once every other day. In other embodiments, the composition may be administered once per week or more. In still other embodiments, the composition may be administered once or more a day.

EXAMPLES

[0020] A male subject suffered from planter's wart on the bottom of his foot for thirty years. Multiple attempts to treat the wart were unsuccessful. The subject was treated with a composition comprising 30% by weight of total composition of 200 ppm the silver- containing substance and 70% by weight of total composition of a combination of unripe fig. The subject was treated once per week for four weeks. After four weeks of treatment, the plantar wart had entirely disappeared with no residual pain, no burning no scarring or open wounds and last but not the least no recurrences after more than 2 years. In other treatments, positive results were also seen with other concentration of silver-containing substance, including 30% by weight of 30 ppm.

[0021] While the present invention has been described in regard to particular embodiments, it is recognized that additional variations of the present invention may be devised without departing from the inventive concept.

Claims

CLAIMS I claim:

1. An antiviral composition for treating a viral condition, comprising:

(a) a therapeutically effective amount of a silver-containing substance;

(b) a therapeutically effective amount of a natural herb; and

(c) a red vinegar, wherein the antiviral composition is suitable for treatment of the viral condition in a subject in need thereof.

2. The antiviral composition of claim 1, wherein the silver containing-substance is colloidal silver.

3. The antiviral composition of claim 2, wherein the natural herb is fig.

4. The antiviral composition of claim 3, wherein the red vinegar is present in an amount from approximately 5% to approximately 90% by weight of the antiviral composition.

5. The antiviral composition of claim 4, wherein the colloidal silver is present in an amount from approximately 1 % to approximately 75 % by weight of the antiviral composition.

6. The antiviral composition of claim 5, wherein the fig is present in an amount from approximately 9% to approximately 94% by weight of the antiviral composition.

7. The antiviral composition of claim 6, wherein the antiviral condition is selected from the group consisting of:

(a) a wart,

(b) a genital wart, and

(c) a disease caused by human papilloma virus.

8. The antiviral composition of claim 1, wherein the red vinegar is present in an amount from approximately 30% to approximately 40% by weight of the antiviral composition.

9. The antiviral composition of claim 1, wherein the red vinegar is present in an amount from approximately 25% to approximately 75% by weight of the antiviral composition.

10. The antiviral composition of claim 1, wherein the red vinegar is present in an amount from approximately 5% to approximately 90% by weight of the antiviral composition.

11. The antiviral composition of claim 1 , wherein the silver-containing substance is selected from the group consisting of colloidal silver, silver nitrate, and any combination thereof.

12. The antiviral composition of claim 11, wherein the silver-containing substance is present in an amount from approximately 1 % to approximately 75 % by weight of the antiviral composition.

13. The antiviral composition of claim 1, wherein the natural herb is present in an amount from approximately 9% to approximately 94% by weight of the antiviral composition.

14. The antiviral composition of claim 1, wherein the natural herb is selected from the group consisting of:

(a) a Rutaceae herb,

(b) a Myrtaceae herb,

(c) a Cupressaceae herb,

(d) a Moraceae herb, and

(e) an antiviral natural herb.

15. The antiviral composition of claim 1, wherein the natural herb is selected from the group consisting of:

(a) Ruta Graveolens,

(b) Melaleuca Alternifolia,

(c) Thuja Occidentalis,

16. The antiviral composition of claim 1 , wherein the natural herb is selected from the group consisting of:

(a) fig;

(b) unripe fig; and

(c) fig latex.

17. The antiviral composition of claim 1, wherein the natural herb is a fig.

18. The antiviral composition of claim 1, wherein the antiviral condition is selected from the group consisting of:

(a) a wart, (b) a genital wart, and

(c) a disease caused by human papilloma virus.

19. A method of treating a viral condition in a subject in need thereof, comprising: administering a therapeutically effective amount of the antiviral compositions as in any of claims 1-6 or 8-17, whereby the viral condition is ameliorated.

20. The method of claim 19, wherein the antiviral condition is selected from the group consisting of:

(a) a wart,

(b) a genital wart, and

(c) a disease caused by human papilloma virus.